头颈癌里程碑试验的历史视角
本文通过检索多个数据库并访谈过去30年头颈癌重大里程碑试验的六位主要研究者,总结临床试验在概念化、实施与报告中的障碍。识别的障碍包括手术试验的方法学与伦理困境、手术干预标准化、外科医生临床流行病学暴露不足及在综合癌症中心外开展试验的后勤问题。受访者与文献提示可通过标准化手术资质认证、外科医生早期参与、与肿瘤内科合作、去中心化及公私合作等策略缓解。
要点
- 访谈六位头颈癌里程碑试验主要研究者并结合文献综述。
- 手术试验面临方法学与伦理困境及手术干预标准化问题。
- 策略包括标准化手术资质认证、外科医生早期参与及去中心化试验。
核心结论
- 领军里程碑临床试验的研究者的洞见提供了将其经验应用于方法学问题与监管挑战并考虑实践要素的机会。
研究设计与样本
- 检索MEDLINE、Embase、Cochrane中央对照试验注册库及ClinicalTrials.gov的头颈癌临床试验文献,并访谈过去30年六位头颈癌重大里程碑试验的主要研究者/资深作者。
主要发现
- 访谈与文献复习识别出手术试验的方法学与伦理困境、手术干预标准化、外科医生缺乏临床流行病学暴露及在综合癌症中心或学术医疗中心之外开展临床试验的后勤问题等障碍。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Understanding the historical perspective, including the evolution, conceptualization, and the issues in implementation of clinical trials, is crucial in developing future clinical trials. DATA SOURCES: A literature search included the following databases: MEDLINE; Embase; Cochrane Central Register of Controlled Trials; and ClinicalTrials.gov for clinical trials on head and neck cancer. REVIEW METHODS: Six principal investigators/senior authors of major landmark trials in head and neck cancers conducted over the past 30 years were interviewed. The goal was to get their insight on factors including conceptualization, writing, conducting, and reporting a clinical trial. RESULTS: Several roadblocks were identified during our interviews and review of relevant literature. These included methodological and ethical dilemmas of surgical trials, standardization of surgical interventions, lack of exposure to clinical epidemiology for surgeons, and issues with the logistics of conducting clinical trials outside a comprehensive cancer center or an academic medical center. The interviewees and literature review provided insight into how these issues could be mitigated. The strategies included standardized surgical credentialing to provide quality assurance and expertise-based surgical trials, involvement of surgeons early in clinical trials, and collaboration with medical oncology colleagues, decentralization of clinical trials, and a private-public partnership to increase clinical trial enrollment. CONCLUSION: Insight from investigators who have spearheaded landmark clinical trials gave us the opportunity to apply their experience with possible regulatory challenges to methodological issues and to consider practical considerations while conducting clinical trials.
引用
- Asarkar AA, Gillespie MB, Nathan CO, et al. Historical Perspective of Landmark Trials in Head and Neck Cancers. Laryngoscope. 2025. PMID: 40801174. doi:10.1002/lary.70038
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。